BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

ViroStatics 

116 Village Boulevard
Suite 200
Princeton  New Jersey  08540  U.S.A.
Phone: 609-951-2206 Fax: 609-213-5287


SEARCH JOBS




Industry
Biotechnology






 Company News
ViroStatics AV-HALT Phase 2a Study in HIV/AIDS Paper Published in PLoS ONE 10/22/2012 9:19:40 AM
ViroStatics CEO, Dr. Franco Lori, to Speak at the International Track During Pennsylvania Biotech 2011 10/24/2011 10:30:39 AM
ViroStatics CEO, Franco Lori, MD, Presents Late Breaker on Novel AV-HALT HIV Therapy at the 2011 International AIDS Society Pathogenesis Conference 7/20/2011 8:42:02 AM
ViroStatics CEO Franco Lori, MD to Present Novel Immune-based Technologies for HIV/AIDS and Chronic Diseases at the 2011 Biotechnology Industry Organization (BIO) International Conference 6/27/2011 10:02:38 AM
ViroStatics Demonstrates Clinical Proof of Concept for Dual Antiviral Anti-Hyperactivation AV-HALT Drugs 3/2/2011 8:55:15 AM
Immunacia’s ViroStatics Reports Phase II Data on VS411, an AV-HALT for Treating HIV/AIDS, During the XVIII International AIDS Conference 7/19/2010 9:43:17 AM
ViroStatics and Vichem Chemie Announce Strategic Partnership to Identify and Develop Kinase Inhibitors for the Treatment of HIV/AIDS and Other Chronic Diseases 6/11/2010 10:49:15 AM
Dr. James Chafouleas Joins ViroStatics and Genetic Immunity as Strategic Adviser 5/3/2010 3:17:56 PM
ViroStatics' Dr. Franco Lori to Present During 2009 Biotechnology Industry Organization (BIO) International Convention in Atlanta 5/18/2009 11:02:50 AM
ViroStatics Acquires Library of Anti-Cancer/Antiviral Compounds From the University of Siena 4/14/2009 11:58:46 AM